Lead compounds are powerful anticancer drugs
Proof-of-concept demonstrated in mouse models of human cancer
Synergy in vitro with commonly used chemotherapeutic agents
Strong scientific team with ties to top universities
Highly experienced management team

OncoNOx ApS

OncoNOx develops novel, proprietary anti-cancer agents. Using our unique medicinal chemistry approach, we transform already marketed compounds into powerful cytotoxic drugs, which potently inhibit cancer in validated animal models